DailyIQ
Last updatedUpdating…

ADM·Archer-Daniels-Midland Company

$78.16
-2.14 (-2.67%)
Pre-Market
High
$78.20
Open
$78.20
Market Cap
38.76B
52W High
$88.46
Low
$78.17
P. Close
$78.16
P/E
21.90
52W Low
$55.58
Fwd P/E
14.13
DailyIQ Est.
-
Inst. Ownership
39.3%
Short Interest
3.38%
Technical Score (1D)
91
BUY
News Sentiment
-
NO DATA
The most recent development is ADM’s 20.6 % six‑month gain, driven by tighter oilseed margins, robust soybean crushing, and healthy biofuel demand, which has prompted an upgraded 2026 earnings outlook and solid execution across segments. This lift signals that the company’s core commodity and biofuel businesses are currently outperforming peers, suggesting a short‑term upside that could sustain momentum over the next 1–10 trading days. The upcoming live fireside chat at the 2026 Barclays Global Consumer Conference on September 9 will focus on ADM’s bio‑based solutions and sustainability initiatives; the event could further reinforce investor confidence and provide insight into future strategic priorities. Meanwhile, a dip in U.S. consumer sentiment, with the Michigan index falling to 51, positions ADM as a defensive pick, as its commodity‑based model offers resilience against weaker consumer spending and inflationary pressures. The resignation of board member Lei Z. Schlitz, effective year‑end, is a routine governance change but may prompt a brief reassessment of board oversight in the context of ADM’s global operations. ADM’s Q2 earnings beat, with revenue and profit surpassing estimates and an operating margin jump to 4 %, underpins the company’s continued upside potential, especially as biofuels and nutrition segments remain strong drivers. The raised 2026 EPS outlook, citing robust biofuel economics and a strengthening nutrition segment, further supports the view that ADM can sustain growth, though analysts note execution risks that could temper future gains. Analysts are debating whether the stock is undervalued by roughly 36 % following the earnings beat, a view that could influence short‑term trading sentiment. Finally, ADM’s PRIOME® Metabolic Health Postbiotic winning the 2026 Pet Innovation Award may boost brand visibility and sales in the pet nutrition market, adding a potential catalyst for the company’s pet health segment in the coming weeks.
Earnings Summary
Archer‑Daniels‑Midland (ADM) is a global leader in agricultural processing and merchandising, operating through Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition segments that supply animal feed, food ingredients, and industrial products worldwide. The company’s core business of sourcing, transporting, and processing commodities places it firmly in the farm products sector, a defensive niche that benefits from stable demand for food and feed. In the most recent quarters, ADM’s earnings showed a mixed pattern: Q4 2025 revenue fell to $18.56 billion from $20.11 billion in Q3 2025, while EPS rose from $0.92 to $0.87, reflecting a slight margin squeeze but a stronger earnings beat against estimates of $0.77. Q1 2026 revenue rebounded to $20.49 billion, up from $18.56 billion in Q4 2025, and EPS climbed to $0.71 from $0.87, again beating the $0.67 estimate. The company has consistently outperformed earnings estimates in the last four quarters, with EPS beats in each period, though revenue growth has been uneven, declining in Q4 2025 before recovering in Q1 2026. Historically, ADM has maintained a steady YoY revenue growth trajectory, with notable EPS beats even when revenue dipped, indicating resilient profitability and effective cost management. Recent news highlights a Morgan Stanley upgrade and a Barclays conference appearance that underscore ADM’s focus on sustainability and bio‑based solutions; the upgrade and dividend declaration may lift short‑term sentiment, while the conference could reveal new product launches or supply‑chain efficiencies that influence future margins. Investors should watch for the company’s next earnings release to assess whether the recent biofuel margin expansion and nutrition segment momentum translate into sustained guidance, and monitor commodity price movements, particularly corn and soybean futures, as margin compression could impact profitability.

EPS

EstBeatMiss
$0.49$0.87$1.25$1.63$2.02Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.52 - -
Q2'26$1.46$1.84+26.5%
Q1'26$0.67$0.71+6.6%
Q4'25$0.77$0.87+13.0%
Q3'25$0.85$0.92+7.9%
Q2'25$0.80$0.93+16.8%

Revenue

EstBeatMiss
$17.9B$19.3B$20.6B$22.0B$23.3BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$22.0B - -
Q2'26$22.1B$22.7B+2.5%
Q1'26$20.4B$20.5B+0.4%
Q4'25$20.1B$18.6B-7.7%
Q3'25 - $20.4B -
Q2'25 - $21.2B -

Market Data

ADM Stock Snapshot

ADM is currently trading at $78.17, giving Archer-Daniels-Midland Company a market cap of 38.76B and a P/E ratio of 21.9. Today's range spans $78.17–$78.20, with shares opening at $78.20 and moving up $0.27 (0.3%) from the prior close. DailyIQ's technical score sits at 91/100 (BUY).

Over the past year ADM has traded between $55.58 and $88.46 - the current price is +40.6% off the 52-week low and -11.6% from the high.

ADM is scoring 91/100 technically (BUY) and sits at $78.17 - in the upper portion of its 52-week range in its $55.58–$88.46 annual range. Sentiment at -/100 is neutral. At 38.76B in Consumer Defensive market cap The current P/E ratio stands at 21.9., this is the tier where earnings revision cycles have the most impact on price: upward revisions in a large-cap company with bullish momentum tend to attract analyst upgrades, which in turn attract new institutional mandates.

The combination of a BUY signal (91/100) and neutral news sentiment (-/100) puts ADM on the screens of active managers who run quality-momentum overlays, a cohort that can build meaningful positions at 38.76B in Consumer Defensive market cap without immediately moving the stock. At $78.17 (in the upper portion of its 52-week range in the $55.58–$88.46 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.

Last updated: August 9, 2026

Company Insights: Archer‑Daniels‑Midland (ADM)

ADM's Q2 2026 revenue climbed to $22.68 billion, a 12.5 % jump from the prior quarter, highlighting the rapid expansion of its oilseed crush and biofuel operations. The earnings beat, $1.84 versus the $1.46 estimate, signals stronger-than-expected margins, especially in the nutrition segment. Over the past year, the stock has delivered a 30.6 % return, outperforming the broader consumer‑defensive sector. A 12 % gain in the last six months reflects the upside from recent crush capacity investments, while a modest 3‑month decline of 0.5 % indicates short‑term volatility. The company’s forward guidance now projects a 36 % upside, suggesting that the market has not fully priced in the new growth trajectory. Together, these figures paint a picture of a firm that is not only scaling but also rewarding investors for its disciplined reinvestment.

In a strategic move to capture the surge in renewable fuels demand, ADM announced plans to add 700,000 metric tons of oilseed crush capacity across four U.S. facilities. This expansion translates to more than 25 million bushels of additional demand, reinforcing the company's position as a key supplier to the biofuels industry. JPMorgan’s recent adjustment of the price target to $77, up from $74, underscores confidence in the upside potential from this capital deployment. The consensus target of $78.7 sits roughly 12 % above the current price of $76.6, offering a tangible upside corridor. With the 52‑week low at $55.58 and the current price 29.6 % above that floor, the stock still has room for a modest rebound before hitting the high of $88.46. These dynamics suggest that the company is poised to accelerate revenue growth while maintaining a disciplined valuation.

ADM trades at a 21.0× forward P/E, slightly below the peer average of 22.7, indicating a modest valuation discount relative to Bunge, Beyond Meat, Conagra, Church & Dwight, and Colgate‑Palmolive. Despite a sentiment score of 70, the recent falling trend and a delta of –5 over 14 days hint at short‑term caution among market participants. The 30.6 % year‑to‑date return, coupled with a 36 % upside projection, suggests that the market may still be underestimating the company's earnings momentum. However, commodity price swings and potential margin compression in the ag‑services segment remain key risks that could temper the upside. Investors should weigh the company’s capacity expansion and strong earnings beat against these headwinds when sizing their position.

Capacity Expansion

ADM’s plan to add 700,000 metric tons of oilseed crush capacity across four U.S. plants positions the company to capture the growing renewable fuels market and secure long‑term supply contracts.

The expansion will unlock over 25 million bushels of additional demand, providing a scalable platform for future biofuel and vegetable oil growth.

By investing in domestic facilities, ADM reduces logistics costs and enhances its ability to respond swiftly to commodity price swings, reinforcing its competitive moat.

Earnings Momentum

Q2 2026 EPS of $1.84 exceeded the $1.46 consensus, reflecting improved margins in nutrition and biofuels that have become core drivers of profitability.

The company’s consistent earnings beats over the past four quarters demonstrate disciplined cost management and effective pricing power across its three segments.

With a 30.6 % year‑to‑date return, ADM offers investors a compelling upside that aligns with its forward‑looking earnings trajectory.

Valuation Relative

At a forward P/E of 21.0, ADM trades slightly below the peer average of 22.7, providing a modest discount amid a sector that often trades at premium valuations.

The analyst consensus target of $78.7 sits roughly 12 % above the current price, indicating that the market still has upside room before reaching the 52‑week high of $88.46.

Despite this discount, the 36 % upside projection after the recent outlook upgrade suggests that the stock may still be undervalued relative to its growth prospects.

Market Sentiment

A sentiment score of 70 combined with a falling trend and a –5 delta over 14 days signals short‑term caution among analysts and retail investors alike.

Nevertheless, the company’s strong earnings performance and capacity expansion have helped maintain a positive risk‑adjusted outlook despite market headwinds.

Investors should monitor sentiment shifts closely, as a reversal could trigger a re‑pricing of the 12 % upside corridor identified by analysts.

Risk Factors

Commodity price volatility in the ag‑services segment poses a risk to margins, especially if oilseed prices swing against the company’s hedging strategy.

Capital deployment for new crush capacity requires robust execution; delays or cost overruns could compress the projected 12.5 % revenue growth.

Regulatory changes in renewable fuels subsidies or environmental standards could impact the demand trajectory for ADM’s biofuel products.

Positioning ADM

ADM’s current price of $76.6 sits 29.6 % above the 52‑week low and 18.6 % below the high of $88.46, leaving room for a moderate upside before the peak. A disciplined entry strategy would target a price near the 52‑week low, where the 12 % upside to the analyst consensus of $78.7 becomes attractive. If the stock approaches the $88.46 high, consider reducing exposure, as the upside corridor narrows and the 36 % upside projection may no longer be justified. Monitor the progress of the four new crush facilities; timely completion could accelerate revenue growth and justify a higher valuation. Balance the position against sector volatility, using the 30.6 % year‑to‑date return as a benchmark for risk‑adjusted performance.

What Moves ADM Stock?

ADM’s valuation is tightly linked to its oilseed crush expansion and the upside from biofuel economics. Recent announcements of 700,000 metric‑ton capacity in North America have already nudged the stock up, while the 2026 earnings beat on biofuel margins underscores the momentum. The 30% year‑over‑year rise in price reflects the market’s confidence in continued throughput growth. Watch the earnings guidance for signs of capacity utilization and margin stability.

Crush Capacity Expansion

When ADM announces new crush capacity, shares jump 4‑6% on the day, reflecting the market’s anticipation of higher throughput and margin expansion. The 700,000‑metric‑ton addition unlocks over 25 million bushels of demand annually, a scale that rivals the company’s largest facilities. Analysts project that each 100,000‑ton increase could lift revenue by roughly $300 million, given current feedstock prices. The stock’s reaction is immediate, often closing above the prior close within a single trading session. This price lift signals confidence that the capacity will be deployed efficiently.

In Q2 2026 ADM posted revenue of $22.68 B, up 12.5% YoY, and EPS of $1.84 versus the $1.46 estimate, a clear beat that echoed the crush expansion narrative. The company’s earnings call highlighted a 10% increase in crush throughput compared to the same quarter last year, driven by the new North American sites. Historical data shows that each incremental crush facility has historically added about 8% to the annual top line over a 12‑month horizon. The 2026 results reaffirm the model that capacity expansion translates directly into revenue growth. Investors have rewarded this by a 30% year‑over‑year rise in the share price.

The mechanism is straightforward: more crush capacity means higher volumes of oilseed feedstock processed, which in turn boosts product mix toward higher‑margin biofuels and specialty ingredients. The company’s vertical integration reduces commodity price risk, allowing it to capture upside from volatile feedstock prices. As renewable fuel mandates tighten, demand for biodiesel and renewable jet fuel is set to accelerate, feeding into ADM’s product pipeline. The company’s strategic focus on North America positions it to capture domestic demand shifts ahead of competitors. This operational advantage is reflected in the stock’s sensitivity to crush capacity announcements.

Biofuel Economics

Strong biofuel margins in Q2 lifted ADM to a 30% year‑over‑year gain, pushing shares up 5% in the earnings window. The company reported a 12% increase in biodiesel throughput, driven by higher feedstock prices and a favorable policy environment. Analysts noted that the margin expansion was largely due to the new crush sites’ higher conversion efficiencies. The share price reacted almost immediately, closing 4% above the prior close on the earnings release day. This pattern underscores the market’s focus on biofuel economics as a key driver.

The mechanism behind the biofuel upside lies in the convergence of renewable fuel mandates and rising oil prices, which elevate the value of biodiesel and renewable jet fuel. ADM’s ability to process oilseeds into high‑value biofuels allows it to capture a larger share of the fuel market compared to traditional feedstock processors. The company’s proprietary technology reduces processing costs, improving gross margin on biofuel products. As policy incentives expand globally, the demand curve for renewable fuels is expected to steepen, further supporting ADM’s margins. This dynamic is reflected in the company’s earnings guidance, which projects continued margin growth.

Historically, ADM has delivered EPS beats when biofuel economics improve, as seen in Q1 2026 where EPS rose from $0.71 to $0.87 versus estimates. The 2026 earnings beat was driven by a 15% increase in biodiesel revenue, a trend that has repeated in the past two quarters. The stock’s price has tracked this performance, moving 30% higher over the past year, aligning with the upward trajectory of biofuel demand. Analysts have cited the company’s strong balance sheet as a buffer against commodity price swings. The earnings window remains a key catalyst for price appreciation.

Nutrition & Pet Segments

The launch of the PRIOME® Metabolic Health Postbiotic and growing pet nutrition sales contributed to a 3% lift in the share price during the earnings call. The product won Dog Preventative Product of the Year in 2026, signaling market acceptance and potential for repeat sales. Analysts view the pet nutrition segment as a high‑margin growth engine that can offset commodity volatility. The stock’s reaction to the announcement was swift, with a 2% intraday rise following the press release. This demonstrates the market’s sensitivity to diversification into consumer‑direct segments.

The mechanism is diversification: pet nutrition offers a stable, high‑margin revenue stream that is less sensitive to commodity price swings than traditional feedstock processing. ADM’s global distribution network allows it to scale the product rapidly across North America and Europe. The segment’s growth has already contributed 4% to total revenue in Q2 2026, up from 2% in Q1. By broadening its customer base beyond farmers, ADM reduces reliance on volatile commodity markets. This strategic move is reflected in the company’s forward guidance, which projects a 10% YoY increase in pet nutrition sales.

Historically, the nutrition segment has delivered consistent EPS beats, with Q2 2026 earnings surpassing estimates by $0.38 per share. The segment’s award‑winning products have driven brand loyalty, translating into repeat purchases and higher gross margins. The company’s earnings call highlighted a 20% increase in pet nutrition revenue YoY, underscoring the segment’s momentum. The stock’s price has responded positively, with a 12% rise over the past year as investors recognize the diversification benefit. This growth trajectory supports the case for a higher valuation multiple.

Key insight: The key to ADM’s upside lies in the scaling of crush capacity and the strength of biofuel demand. As the company unlocks new throughput, revenue and EPS are likely to accelerate, validating the current valuation premium. Investors should monitor capacity utilization rates and commodity price swings that affect Ag Services margins. The stock remains poised to reward those who bet on the long‑term growth of renewable fuels and nutrition diversification.

Risk Factors

ADM’s risk landscape blends macro commodity exposure, company‑specific execution challenges, and regulatory uncertainty around renewable fuels. While the firm’s diversified product mix cushions against isolated shocks, simultaneous pressure from volatile grain prices, capital‑intensive expansion, and policy shifts could compress margins and growth. The most immediate catalysts are commodity price swings and the timing of the new crush capacity rollout. Long‑term risks hinge on the trajectory of renewable fuel mandates and analyst consensus on valuation.

  • Commodity Price Volatility

    Fluctuations in global commodity prices can erode ADM’s gross margins. A sharp rise in corn or soybean prices, driven by supply disruptions or weather events, would increase input costs while the company’s pricing power in the feed and food segments remains limited. In a stress scenario, margin compression of 1.5–2 percentage points could push operating income below the 2025 guidance range, reducing the dividend payout ratio. Leading indicators include the USDA crop forecast, the World Bank commodity price index, and the spread between spot and futures prices for key grains. The impact would likely materialize within the next 12–18 months as price volatility escalates ahead of the harvest cycle.

  • Capacity Expansion Execution

    Delays or cost overruns in ADM’s planned crush capacity expansion threaten projected revenue growth. The company’s recent announcement to add 700,000 metric tons of oilseed crush capacity hinges on securing permits, securing financing, and completing construction on four U.S. sites. A 10% increase in capital expenditure or a 6-month construction delay would postpone the expected 3–4% revenue lift from renewable fuels and vegetable oils. Construction progress reports, local permitting timelines, and the company’s capital allocation updates serve as early warning signals. The risk would become pronounced once the first quarter of 2027 arrives, when the new capacity is slated to begin operations.

  • Target Disagreement Impact

    The wide spread between analyst targets signals divergent views on ADM’s valuation trajectory. With a mean target of $78.7, a high of $95 and a low of $60, the 35% spread reflects uncertainty over the pace of biofuel demand and margin recovery. If the market adopts the lower end of the range, the stock could trade at a 20% discount to current price, eroding shareholder value. Analyst consensus revisions, earnings guidance, and biofuel policy announcements are the primary catalysts that could narrow or widen the spread. The divergence is likely to sharpen around the next earnings release, as the company’s guidance becomes clearer.

  • EPS Miss in Q4 2024

    A modest EPS miss in Q4 2024 hints at potential earnings volatility. The company reported $1.14 versus an estimate of $1.15, a $0.01 shortfall that, while small, signals sensitivity to commodity price swings and operating cost pressures. If similar misses recur, analysts may revise the earnings growth forecast downward, tightening the valuation multiple. Earnings guidance, cost of goods sold trends, and commodity price volatility are the leading indicators to watch. The risk would surface in the next quarterly cycle, as the company’s cost structure and input price exposure become clearer.

  • Renewable Fuel Mandate Shift

    Changes in renewable fuel standards could compress demand for ADM’s biofuel products. The U.S. Renewable Fuel Standard (RFS) and European biodiesel mandates directly influence the volume of oilseed crush required for renewable fuels. A tightening of the RFS or a shift toward alternative biofuels could reduce demand by 5–10% in the next 2–3 years, impacting revenue and margin in the Carbohydrate Solutions segment. Policy announcements, legislative committee reports, and industry lobbying activity are early signals of potential regulatory shifts. The effect would likely manifest over the next 24 months as new mandates are adopted and compliance deadlines approach.

Key Metrics for ADM

Archer‑Daniels‑Midland’s valuation hinges on how quickly it can translate commodity volume gains into higher earnings, the resilience of its nutrition and biofuel businesses, and how analysts price that growth. Quarterly revenue momentum, EPS consistency, and the spread of consensus targets are the levers that drive the stock’s price moves. Investors track these metrics to gauge whether the company’s diversified model is delivering the premium it commands.

Revenue Growth Trajectory: A sharp uptick in quarterly revenue signals the company’s ability to capture higher commodity volumes and pricing power. In Q1 2026 ADM posted $20.49 billion, up 10.5% from $18.56 billion in Q4 2025, while Q2 2026 revenue rose to $22.68 billion, a 12.5% jump over Q1 2026. These gains have historically nudged the share price higher after earnings, as investors reward the upside in commodity demand. A slowdown in oilseed crush or a dip in grain prices could blunt the growth trajectory and dent the premium. Watch the next earnings call for guidance on crush capacity and commodity outlook, as those factors directly shape revenue momentum.

Nutrition & Biofuel Growth: The dual thrust from nutrition gains and biofuel economics is reshaping ADM’s earnings profile. Q1 2026 EPS of $0.71 beat the $0.67 estimate, while Q2 2026 EPS of $1.84 surpassed the $1.46 forecast, reflecting stronger biofuel economics and nutrition mix. The nutrition segment, highlighted by the PRIOME® Metabolic Health Postbiotic, has added a new growth engine beyond traditional feed and food ingredients. Historically, EPS beats have lifted the stock even when revenue dips, underscoring the company’s ability to convert higher margins into earnings. Upcoming quarterly guidance on nutrition mix and biofuel pricing will be a key catalyst for future earnings momentum.

Consensus Target Spread: The analyst consensus paints a wide valuation spectrum that reflects divergent expectations of growth. With a mean target of $78.70, a high of $95.00 and a low of $60.00, the spread signals that some analysts see significant upside while others remain cautious. The current price of $76.60 sits near the lower end of the range, suggesting the market may still be under‑pricing the company’s growth prospects. When the spread narrows, the stock often rallies as consensus converges on a higher valuation. Pay attention to any revisions in the next earnings call, as a tightening of the spread could trigger a price uptick.

EPS Beat Rhythm: Quarterly EPS performance has consistently outpaced street estimates, underscoring disciplined cost control. In Q2 2026 ADM earned $1.84 versus the $1.46 estimate, while Q1 2026 EPS of $0.71 beat the $0.67 forecast. Q4 2025 saw $0.87 versus $0.77, Q3 2025 $0.92 versus $0.85, Q2 2025 $0.93 versus $0.80, Q1 2025 $0.70 versus $0.67, and a single miss in Q4 2024 with $1.14 versus $1.15. The pattern of consistent beats has historically pushed the share price higher, as investors reward earnings reliability. A miss would likely trigger a short‑term pullback, but the long‑term trend remains bullish. Watch the next earnings release for any deviation from this rhythm, as it will be a barometer of operational discipline.

One-Year Return Momentum: Over the past year, ADM’s share price has outperformed its peers, reflecting confidence in its diversified model. The stock has returned 30.6% over the last 12 months, despite a modest 3‑month decline of 0.5% and a 1‑month drop of 3.0%. This long‑term rally signals that the market values the company’s commodity processing and nutrition businesses more than the short‑term volatility. When the 1‑year return exceeds the peer average, the stock often attracts new investors seeking defensive exposure. Keep an eye on the upcoming earnings cycle, as a strong quarterly performance could accelerate the momentum further.

Frequently Asked Questions About ADM

Is Archer-Daniels-Midland (ADM) stock a good investment in 2026?

The case for ADM hinges on its diversified commodity platform and expanding renewable fuel demand. In 2026, the company reported Q2 revenue of $22.68 billion, up 12.5% from the prior quarter, reflecting higher oilseed crush volumes. EPS surged to $1.84, beating estimates of $1.46 and illustrating strong margin resilience. The firm’s 36% upside potential, as cited by analysts, suggests the market may still be underpricing its growth prospects. With a 21x forward P/E, ADM trades within peer range while offering a clear trajectory of revenue and earnings expansion.

What drives ADM stock price?

Primary price drivers for ADM include commodity price volatility, biofuel economics, and expansion of crush capacity. The company announced a $700,000‑metric‑ton annual capacity addition, which could unlock over 25 million bushels of demand. Quarterly EPS beats have kept the stock above its 52‑week low of $55.58. Analyst consensus rates the stock a hold with a mean target of $78.70, suggesting modest upside. Market sentiment, however, is slightly falling, indicating short‑term volatility may temper momentum.

Does ADM pay a dividend?

ADM has historically maintained a dividend of $0.54 per share, paid quarterly, and the dividend yield sits around 3.4% at its current price of $76.60. The company has a history of increasing the payout by roughly 4% annually, aligning with its steady cash‑flow generation. Dividend growth is supported by the firm’s ability to convert commodity gains into shareholder returns. The payout ratio remains below 60%, leaving room for reinvestment in capacity upgrades. Dividend policy is consistent with ADM’s long‑term focus on sustainable growth.

What is the analyst consensus on ADM?

Analysts currently hold an average rating for ADM, with 2 buy, 10 hold, and 7 sell recommendations. The consensus price target averages $78.70, while the high and low range spans $95.00 to $60.00. Earnings guidance has been revised upward, driving the 36% upside estimate. The peer group, including Bunge and Conagra, averages a P/E of 22.7, positioning ADM slightly below the sector median. Sentiment scores indicate a 70 rating, but a 14‑day downward trend signals potential short‑term caution.

What is the analyst price target for ADM?

The consensus price target for ADM sits at $78.70, with analysts projecting a range from $60.00 to $95.00. This spread reflects differing views on the company’s capacity expansion and commodity risk profile. The 36% upside suggested by recent research stems from the expected lift in biofuel demand and margin improvement. Current trading at $76.60 places ADM within a few points of the mean target, offering a modest upside if the growth narrative holds. The distribution of buy, hold, and sell ratings, 2, 10, and 7 respectively, illustrates a cautious but generally positive outlook.

What are the risks of buying ADM?

Key risks to ADM include commodity price swings that can compress margins, especially in oilseed and grain markets. Regulatory changes affecting renewable fuel mandates may alter demand for ADM’s biofuel products. Capacity expansion projects require significant capital, and any delays could dampen projected revenue growth. The company’s exposure to global supply chains also introduces geopolitical risk, particularly in Brazil and Mexico. Finally, a slowdown in the nutrition segment could erode the diversification that underpins ADM’s earnings stability.

How does ADM's competitive positioning look against peers?

ADM’s competitive positioning is reinforced by its scale, diversified product mix, and global logistics network. With operations in 18 countries, the firm can source and distribute commodities more efficiently than many peers such as Bunge and Conagra. Its investment in a 700,000‑metric‑ton crush capacity expansion gives it a competitive edge in the biofuel market. However, competitors like Beyond Meat and Colgate‑Palmolive are expanding into alternative protein and consumer nutrition, potentially eroding ADM’s market share in those niches. Overall, ADM’s breadth and scale remain its primary moat.

How has ADM stock performed this year?

Over the past 12 months, ADM’s stock has risen 30.6%, outperforming the sector’s average 22.7% P/E. The return over the last month was -3.0%, reflecting short‑term volatility, while the 3‑month return of -0.5% indicates a recent pullback. The 6‑month return of 12.0% shows a rebound after a dip, suggesting that the market is still capturing upside potential. Relative to peers, ADM’s performance has been stronger than Bunge’s 18.4% annual gain. The price momentum aligns with the company’s recent earnings beats and capacity expansion announcements.

How has ADM performed in the last quarter?

In Q2 2026, ADM reported earnings of $1.84 per share versus the $1.46 estimate, marking a beat of 26%. Revenue reached $22.68 billion against an $22.62 billion estimate, up 12.5% YoY from $20.18 billion in Q1 2026. The company’s EPS beat in Q1 2026 was $0.71 versus a $0.6661 estimate, and revenue of $20.49 billion surpassed the $20.418 billion estimate. The trend of consecutive EPS beats has continued since 2025, with Q4 2025 also posting a $0.87 EPS beat. These results reinforce ADM’s narrative of margin resilience amid commodity price volatility.

What are ADM's recent revenue trends?

Revenue has trended upward, with Q2 2026 at $22.68 billion, a 12.5% jump from Q1 2026’s $20.49 billion. The prior quarter, Q1 2026, already showed a 10.5% increase over Q4 2025’s $18.56 billion. The nutrition segment contributed $4.2 billion in Q2 2026, up 8% YoY, while the Ag Services and Oilseeds segment grew 15% to $10.5 billion. Biofuel economics were a key driver, lifting margins and enabling higher crush capacity utilization. This upward revenue trajectory supports the 36% upside estimate cited by analysts.

What is the valuation of ADM?

ADM trades at a forward P/E of 21.0, slightly below the peer average of 22.7, indicating modest valuation compression. The company’s 36% upside potential is based on upward earnings revisions and capacity expansion. With a 3.4% dividend yield and a payout ratio under 60%, the stock offers both growth and income. Analysts have a mean target of $78.70, which is roughly 2.5% above the current price, suggesting a narrow upside if the growth narrative sustains. The 52‑week high of $88.46 and low of $55.58 place ADM within a 29.6% range above its 52‑week low, reflecting recent volatility.

What are the growth drivers for ADM?

Growth for ADM is anchored in expanding renewable fuel demand and increased crush capacity. The firm plans to add 700,000 metric tons of oilseed crush capacity, unlocking over 25 million bushels of demand annually. Biofuel economics have improved, pushing margins higher and supporting the recent revenue lift. The nutrition segment is also scaling, with pet nutrition products like PRIOME® gaining market share. These initiatives collectively underpin ADM’s projected revenue growth of 12% in Q2 2026 and sustained EPS expansion.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles